Back to search

Differentiating hyperlipidaemia associated with antiretroviral therapy

Data up to Jan 2025

Published2003
Citations33
References28

Total Citations Per Year

Abstract

References (28)

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study

1999 • 1,549 citations

Drug Treatment of Lipid Disorders

1999 • 863 citations

Classification of Hyperlipidaemias and Hyperlipoproteinaemias ,

1972 • 843 citations

Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome.

1992 • 784 citations

Atherogenic Dyslipidemia in HIV-Infected Individuals Treated With Protease Inhibitors

1999 • 615 citations

A Short-Term Study of the Safety, Pharmacokinetics, and Efficacy of Ritonavir, an Inhibitor of HIV-1 Protease

1995 • 569 citations

Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors

1999 • 533 citations

Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection

2000 • 527 citations

Effects of Protease Inhibitors on Hyperglycemia, Hyperlipidemia, and Lipodystrophy

2000 • 465 citations

Hypertriglyceridemia in the acquired immunodeficiency syndrome

1989 • 446 citations

Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects

2000 • 398 citations

Fat distribution and metabolic changes in patients with HIV infection

1999 • 380 citations

Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO* study

2000 • 366 citations

Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome

1992 • 341 citations

Myocardial infarction in the familial forms of hypertriglyceridemia

1976 • 308 citations

Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia

1983 • 305 citations

Premature atherosclerosis in HIV-infected individuals – focus on protease inhibitor therapy

2001 • 284 citations

Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors

2000 • 249 citations

Natural history of serum HIV-1 RNA levels in 330 patients with a known date of infection

2000 • 197 citations

Hyperlipidemia and Insulin Resistance Are Induced by Protease Inhibitors Independent of Changes in Body Composition in Patients With HIV Infection

2000 • 192 citations

Vascular complications associated with use of HIV protease inhibitors

1998 • 168 citations

Assessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease inhibitors☆☆☆★

2002 • 127 citations

Endogenous interferon and triglyceride concentrations to assess response to zidovudine in AIDS and advanced AIDS-related complex

1992 • 104 citations

Antiretroviral therapy-associated hyperlipidaemia in HIV disease

2001 • 101 citations

Apoprotein C-III and E-Containing Lipoparticles Are Markedly Increased in HIV-Infected Patients Treated with Protease Inhibitors: Association with the Development of Lipodystrophy

2001 • 80 citations

Severe hypertriglyceridemia: Role of familial and acquired disorders

1983 • 71 citations

Excess coronary heart disease in Familial Combined Hyperlipidemia, in relation to genetic factors and central obesity

2001 • 69 citations

Apoprotein C-III and E-Containing Lipoparticles Are Markedly Increased in HIV-Infected Patients Treated with Protease Inhibitors: Association with the Development of Lipodystrophy

2001 • 26 citations

Cited By (0)

Loading...